miR-199a-5p Is Upregulated during Fibrogenic Response to Tissue Injury and Mediates TGFbeta-Induced Lung Fibroblast Activation by Targeting Caveolin-1

PLoS Genetics

Volumn 9, Issue 2, 2013, Pages

  Lino Cardenas, Christian Lacks ^a   Henaoui, Imène Sarah ^b,c   Courcot, Elisabeth ^a   Roderburg, Christoph ^d   Cauffiez, Christelle ^a   Aubert, Sébastien ^e,f,g   Copin, Marie Christine ^e,f,g   Wallaert, Benoit ^f   Glowacki, François ^a   Dewaeles, Edmone ^a   Milosevic, Jadranka ^h   Maurizio, Julien ^b,c   Tedrow, John ^h   Marcet, Brice ^b,c   Lo Guidice, Jean Marc ^a   Kaminski, Naftali ^h   Barbry, Pascal ^b,c   Luedde, Tom ^d   Perrais, Michael ^e,g   Mari, Bernard ^b,c   Pottier, Nicolas ^a   more..

^a France Institut Pasteur de Lille   (France)

^b CNRS   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e INSERM   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g UNIV LILLE   (France)

^h UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBON TETRACHLORIDE; CAVEOLIN 1; MICRORNA; MICRORNA 199A 5P; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROSING ALVEOLITIS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FIBROSIS; LIVER FIBROSIS; LUNG FIBROBLAST; MAJOR CLINICAL STUDY; MALE; MOUSE; MOUSE STRAIN; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TISSUE INJURY; UPREGULATION;

ANIMALS; BLEOMYCIN; CAVEOLIN 1; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MICE; MICRORNAS; NEOPLASM INVASIVENESS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 84874779817     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003291     Document Type: Article

References (73)

1. Wynn TA, (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117: 524-529.
2. Wilson MS, Wynn TA, (2009) Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2: 103-121.
3. Kis K, Liu X, Hagood JS, (2011) Myofibroblast differentiation and survival in fibrotic disease. Expert Rev Mol Med 13: e27.
4. Wightman B, Ha I, Ruvkun G, (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855-862.
5. Lee RC, Feinbaum RL, Ambros V, (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
6. Griffiths-Jones S, (2006) miRBase: the microRNA sequence database. Methods Mol Biol 342: 129-138.
7. Sayed D, Abdellatif M, (2011) MicroRNAs in development and disease. Physiol Rev 91: 827-887.
8. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
9. Sheedy FJ, O'Neill LA, (2008) Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 67 (Suppl 3):: iii50-iii55.
10. O'Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, et al. (2010) MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci U S A 107: 14235-14240.
11. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, et al. (2010) Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18: 282-293.
12. Pichiorri F, Suh SS, Rocci A, De LL, Taccioli C, et al. (2010) Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 18: 367-381.
13. Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, et al. (2010) Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182: 220-229.
14. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, et al. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207: 1589-1597.
15. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
16. Lawson WE, Blackwell TS, Gauldie J, (2011) Let It Be: microRNAs Impact Interstitial Lung Disease. Am J Respir Crit Care Med 183: 1-2.
17. Pandit KV, Milosevic J, Kaminski N, (2011) MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 157: 191-199.
18. Drab M, Verkade P, Elger M, Kasper M, Lohn M, et al. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452.
19. Wang XM, Zhang Y, Kim HP, Zhou Z, Feghali-Bostwick CA, et al. (2006) Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 203: 2895-2906.
20. Shivshankar P, Brampton C, Miyasato S, Kasper M, Thannickal VJ, et al. (2012) Caveolin-1 Deficiency Protects from Pulmonary Fibrosis by Modulating Epithelial Cell Senescence in Mice. Am J Respir Cell Mol Biol 47: 28-36.
21. Yamaguchi Y, Yasuoka H, Stolz DB, Feghali-Bostwick CA, (2011) Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5. J Cell Mol Med 15: 957-969.
22. Schrier DJ, Kunkel RG, Phan SH, (1983) The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 127: 63-66.
23. Haston CK, Amos CI, King TM, Travis EL, (1996) Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse. Cancer Res 56: 2596-2601.
24. Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, et al. (2007) Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315: 1579-1582.
25. Pottier N, Maurin T, Chevalier B, Puissegur MP, Lebrigand K, et al. (2009) Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS ONE 4: e6718 doi:10.1371/journal.pone.0006718.
26. Puissegur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, et al. (2011) miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ 18: 465-478.
27. Zarjou A, Yang S, Abraham E, Agarwal A, Liu G, (2011) Identification of a microRNA signature in renal fibrosis: Role of miR-21. Am J Physiol Renal Physiol 301: F793-801.
28. Li S, Liang Z, Xu L, Zou F, (2011) MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases. Mol Cell Biochem 360: 147-158.
29. Le Brigand K, Robbe-Sermesant K, Mari B, Barbry P, (2010) MiRonTop: mining microRNAs targets across large scale gene expression studies. Bioinformatics 26: 3131-3132.
30. Xia H, Khalil W, Kahm J, Jessurun J, Kleidon J, et al. (2010) Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Am J Pathol 176: 2626-2637.
31. Odajima N, Betsuyaku T, Nasuhara Y, Nishimura M, (2007) Loss of caveolin-1 in bronchiolization in lung fibrosis. J Histochem Cytochem 55: 899-909.
32. Tourkina E, Richard M, Gooz P, Bonner M, Pannu J, et al. (2008) Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 294: L843-L861.
33. Kim HP, Choi AM, (2008) Caveolin-1 stops profibrogenic signaling? Am J Physiol Lung Cell Mol Physiol 294: L841-L842.
34. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
35. Lu J, Getz G, Miska EA, varez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
36. Zhang C, (2008) MicroRNomics: a newly emerging approach for disease biology. Physiol Genomics 33: 139-147.
37. Xie T, Liang J, Guo R, Liu N, Noble PW, et al. (2011) Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiol Genomics 43: 479-487.
38. Ogawa T, Enomoto M, Fujii H, Sekiya Y, Yoshizato K, et al. (2012) MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut 61: 1600-1609.
39. Lize M, Pilarski S, Dobbelstein M, (2010) E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Cell Death Differ 17: 452-458.
40. Marcet B, Chevalier B, Luxardi G, Coraux C, Zaragosi LE, et al. (2011) Control of vertebrate multiciliogenesis by miR-449 through direct repression of the Delta/Notch pathway. Nat Cell Biol 13: 693-699.
41. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, et al. (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68: 425-433.
42. Chakrabarty A, Tranguch S, Daikoku T, Jensen K, Furneaux H, et al. (2007) MicroRNA regulation of cyclooxygenase-2 during embryo implantation. Proc Natl Acad Sci U S A 104: 15144-15149.
43. Friedman LM, Dror AA, Mor E, Tenne T, Toren G, et al. (2009) MicroRNAs are essential for development and function of inner ear hair cells in vertebrates. Proc Natl Acad Sci U S A 106: 7915-7920.
44. Lin EA, Kong L, Bai XH, Luan Y, Liu CJ, (2009) miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. J Biol Chem 284: 11326-11335.
45. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, et al. (2008) MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111: 3183-3189.
46. Iorio MV, Visone R, Di LG, Donati V, Petrocca F, et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res 67: 8699-8707.
47. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, et al. (2010) Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11: 136-146.
48. Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, et al. (2011) The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS ONE 6: e16081 doi:10.1371/journal.pone.0016081.
49. Kanda T, Ishibashi O, Kawahigashi Y, Mishima T, Kosuge T, et al. (2010) Identification of obstructive jaundice-related microRNAs in mouse liver. Hepatogastroenterology 57: 1013-1023.
50. Severs NJ, (1988) Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact? J Cell Sci 90 (Pt 3) (): 341-348.
51. Williams TM, Lisanti MP, (2004) The Caveolin genes: from cell biology to medicine. Ann Med 36: 584-595.
52. Chen YG, Wang XF, (2009) A special issue on TGF-beta signaling. Cell Res 19: 1-2.
53. Zhang Y, Fan KJ, Sun Q, Chen AZ, Shen WL, et al. (2012) Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-beta signalling pathway. Nucleic Acids Res 40: 9286-9297.
54. Swaisgood CM, French EL, Noga C, Simon RH, Ploplis VA, (2000) The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 157: 177-187.
55. Bonniaud P, Margetts PJ, Kolb M, Schroeder JA, Kapoun AM, et al. (2005) Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med 171: 889-898.
56. Yamashita CM, Dolgonos L, Zemans RL, Young SK, Robertson J, et al. (2011) Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis. Am J Pathol 179: 1733-1745.
57. Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, et al. (2002) Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 22: 2329-2344.
58. Kumarswamy R, Volkmann I, Thum T, (2011) Regulation and function of miRNA-21 in health and disease. RNA Biol 8: 706-713.
59. Davis BN, Hilyard AC, Lagna G, Hata A, (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61.
60. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A, (2010) Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 39: 373-384.
61. Moore J, McKnight AJ, Simmonds MJ, Courtney AE, Hanvesakul R, et al. (2010) Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure. JAMA 303: 1282-1287.
62. Park HC, Yasuda K, Ratliff B, Stoessel A, Sharkovska Y, et al. (2010) Postobstructive regeneration of kidney is derailed when surge in renal stem cells during course of unilateral ureteral obstruction is halted. Am J Physiol Renal Physiol 298: F357-F364.
63. Bataller R, Brenner DA, (2005) Liver fibrosis. J Clin Invest 115: 209-218.
64. Pottier N, Chupin C, Defamie V, Cardinaud B, Sutherland R, et al. (2007) Relationships between early inflammatory response to bleomycin and sensitivity to lung fibrosis: a role for dipeptidyl-peptidase I and tissue inhibitor of metalloproteinase-3? Am J Respir Crit Care Med 176: 1098-1107.
65. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, et al. (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53: 209-218.
66. Demedts M, Costabel U, (2002) ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J 19: 794-796.
67. Steele MP, Speer MC, Loyd JE, Brown KK, Herron A, et al. (2005) Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 172: 1146-1152.
68. Griffiths-Jones S, Grocock RJ, van DS, Bateman A, Enright AJ, (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-D144.
69. Wu W, Dave N, Tseng GC, Richards T, Xing EP, et al. (2005) Comparison of normalization methods for CodeLink Bioarray data. BMC Bioinformatics 6: 309.
70. Le BK, Barbry P, (2007) Mediante: a web-based microarray data manager. Bioinformatics 23: 1304-1306.
71. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
72. van DS, Breu-Goodger C, Enright AJ, (2008) Detecting microRNA binding and siRNA off-target effects from expression data. Nat Methods 5: 1023-1025.
73. Rosenbloom J, Castro SV, Jimenez SA, (2010) Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies. Ann Intern Med 152: 159-166.